Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 102
of 6Next
1:

Ovarian cancer, the coagulation pathway, and inflammation.

Wang X, Wang E, Kavanagh JJ, Freedman RS.

J Transl Med. 2005 Jun 21;3:25.

PMID: 15969748 [PubMed]

2:

Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer.

Freedman RS, Wang E, Voiculescu S, Patenia R, Bassett RL Jr, Deavers M, Marincola FM, Yang P, Newman RA.

Clin Cancer Res. 2007 Oct 1;13(19):5736-44.

PMID: 17908963 [PubMed - indexed for MEDLINE]

3:

Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC).

Freedman RS, Deavers M, Liu J, Wang E.

J Transl Med. 2004 Jun 25;2(1):23.

PMID: 15219235 [PubMed - as supplied by publisher]

4:

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID: 17993229 [PubMed - indexed for MEDLINE]

5:

Role of current and emerging antithrombotics in thrombosis and cancer.

Mousa SA.

Drugs Today (Barc). 2006 May;42(5):331-50. Review.

PMID: 16801996 [PubMed - indexed for MEDLINE]

6:

Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.

Zhang H, Stephens LC, Kumar R.

Clin Cancer Res. 2006 Mar 1;12(5):1479-86.

PMID: 16533771 [PubMed - indexed for MEDLINE]

7:

Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.

Rak J, Klement P, Yu J.

Vnitr Lek. 2006 Mar;52 Suppl 1:135-8. Review.

PMID: 16637463 [PubMed - indexed for MEDLINE]

8:

Role of current and emerging antithrombotics in thrombosis and cancer.

Mousa SA.

Timely Top Med Cardiovasc Dis. 2006 Aug 1;10:E19.

PMID: 17066136 [PubMed]

9:

A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling.

Posadas EM, Kwitkowski V, Kotz HL, Espina V, Minasian L, Tchabo N, Premkumar A, Hussain MM, Chang R, Steinberg SM, Kohn EC.

Cancer. 2007 Jul 15;110(2):309-17.

PMID: 17559139 [PubMed - indexed for MEDLINE]

10:

Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease.

Wang X, Deavers M, Patenia R, Bassett RL Jr, Mueller P, Ma Q, Wang E, Freedman RS.

J Transl Med. 2006 Jul 6;4:30.

PMID: 16824216 [PubMed]

11:

Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.

Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A, Suri A.

Clin Cancer Res. 2007 Mar 1;13(5):1421-8.

PMID: 17332284 [PubMed - indexed for MEDLINE]

12:

Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma.

Wojtukiewicz MZ, Zacharski LR, Ruciñska M, Zimnoch L, Jaromin J, Rózañska-Kudelska M, Kisiel W, Kudryk BJ.

Thromb Haemost. 1999 Dec;82(6):1659-62.

PMID: 10613652 [PubMed - indexed for MEDLINE]

13:

Coagulation cascade activation causes CC chemokine receptor-2 gene expression and mononuclear cell activation in hemodialysis patients.

Pertosa G, Simone S, Soccio M, Marrone D, Gesualdo L, Schena FP, Grandaliano G.

J Am Soc Nephrol. 2005 Aug;16(8):2477-86. Epub 2005 Jun 23. Erratum in: J Am Soc Nephrol. 2006 Feb;17(2):591. J Am Soc Nephrol. 2006 May;17(5):1489.

PMID: 15976001 [PubMed - indexed for MEDLINE]

14:

Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.

Rak J, Milsom C, May L, Klement P, Yu J.

Semin Thromb Hemost. 2006 Feb;32(1):54-70. Review.

PMID: 16479463 [PubMed - indexed for MEDLINE]

15:

Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk.

Cicala C, Cirino G.

Life Sci. 1998;62(20):1817-24. Review.

PMID: 9600323 [PubMed - indexed for MEDLINE]

16:

Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.

Coutinho A, Caramalho I, Seixas E, Demengeot J.

Curr Top Microbiol Immunol. 2005;293:43-71. Review.

PMID: 15981475 [PubMed - indexed for MEDLINE]

17:

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.

Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, Becker AR, Turkyilmaz MA, Salgia R, Yamada SD, Vande Woude GF, Tretiakova MS, Lengyel E.

Cancer Res. 2007 Feb 15;67(4):1670-9.

PMID: 17308108 [PubMed - indexed for MEDLINE]

18:

Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.

Koizume S, Jin MS, Miyagi E, Hirahara F, Nakamura Y, Piao JH, Asai A, Yoshida A, Tsuchiya E, Ruf W, Miyagi Y.

Cancer Res. 2006 Oct 1;66(19):9453-60.

PMID: 17018600 [PubMed - indexed for MEDLINE]

19:

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID: 17472413 [PubMed - indexed for MEDLINE]

20:

[Expression evaluation of in loco coagulation system in colorectal cancer]

Sierko E, Tokajuk P, Butkiewicz A, Sulkowski S, Zimnoch L, Wojtukiewicz MZ.

Pol Merkur Lekarski. 2005 Feb;18(104):176-9. Polish.

PMID: 17877125 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 102
of 6Next